Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Selective association of cytokine levels and kynurenine/tryptophan ratio with alterations in white matter microstructure in bipolar but not in unipolar depression
Stefano Comai, Elisa Melloni, Cristina Lorenzi, et al.
European Neuropsychopharmacology (2021) Vol. 55, pp. 96-109
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Inflammatory mediators in major depression and bipolar disorder
Sara Poletti, Mario Gennaro Mazza, Francesco Benedetti
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 29
Low-dose interleukin 2 antidepressant potentiation in unipolar and bipolar depression: Safety, efficacy, and immunological biomarkers
Sara Poletti, Raffaella Zanardi, Alessandra Mandelli, et al.
Brain Behavior and Immunity (2024) Vol. 118, pp. 52-68
Open Access | Times Cited: 25
Neuroactive Kynurenines as Pharmacological Targets: New Experimental Tools and Exciting Therapeutic Opportunities
Ana Pocivavsek, Robert Schwarcz, Sophie Erhardt
Pharmacological Reviews (2024) Vol. 76, Iss. 6, pp. 978-1008
Closed Access | Times Cited: 9
Association between Diffusion Tensor Imaging, inflammation and immunological alterations in unipolar and bipolar depression: A review
Rosario Aronica, Paolo Enrico, Letizia Squarcina, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 143, pp. 104922-104922
Closed Access | Times Cited: 31
An integrated cytokine and kynurenine network as the basis of neuroimmune communication
Trevor W. Stone, Felix I. L. Clanchy, Yishu Huang, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 27
C-Reactive protein and the kynurenic acid to quinolinic acid ratio are independently associated with white matter integrity in major depressive disorder
Haixia Zheng, T. Kent Teague, Fang‐Cheng Yeh, et al.
Brain Behavior and Immunity (2022) Vol. 105, pp. 180-189
Open Access | Times Cited: 24
Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients
Zhiyu Jin, Yu Han, Danshen Zhang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2070-2070
Open Access | Times Cited: 24
The kynurenine pathway in treatment-resistant schizophrenia at the crossroads between pathophysiology and pharmacotherapy
Jacopo Sapienza, Giulia Agostoni, Stefano Dall’Acqua, et al.
Schizophrenia Research (2023) Vol. 264, pp. 71-80
Closed Access | Times Cited: 14
Inflammatory Biomarkers, Cognitive Functioning, and Brain Imaging Abnormalities in Bipolar Disorder: A Systematic Review.
A Mario, Leccisotti Ivana, Mollica Anita, et al.
PubMed (2024) Vol. 21, Iss. 1, pp. 32-62
Closed Access | Times Cited: 6
Neuroinflammation and kynurenines in schizophrenia: Impact on cognition depending on cognitive functioning and modulatory properties in relation to cognitive remediation and aerobic exercise
Jacopo Sapienza, Giulia Agostoni, Stefano Comai, et al.
Schizophrenia Research Cognition (2024) Vol. 38, pp. 100328-100328
Open Access | Times Cited: 6
Dysfunction in endocannabinoids, palmitoylethanolamide, and degradation of tryptophan into kynurenine in individuals with depressive symptoms
Stefano Comai, Nicolás A. Núñez, Tobias Atkin, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine
Sourav Khanra, P. Hemachandra Reddy, Anna Giménez‐Palomo, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 8, pp. 3231-3242
Open Access | Times Cited: 12
The Complex World of Kynurenic Acid: Reflections on Biological Issues and Therapeutic Strategy
Trevor W. Stone, L. Gail Darlington, Abdulla A.‐B. Badawy, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 9040-9040
Open Access | Times Cited: 4
The association of kynurenine pathway metabolites with symptom severity and clinical features of bipolar disorder: An overview
Francesco Bartoli, R. Cioni, Daniele Cavaleri, et al.
European Psychiatry (2022) Vol. 65, Iss. 1
Open Access | Times Cited: 19
Importance of the dysregulation of the kynurenine pathway on cognition in schizophrenia: a systematic review of clinical studies
Jacopo Sapienza, Marco Spangaro, Gilles J. Guillemin, et al.
European Archives of Psychiatry and Clinical Neuroscience (2022) Vol. 273, Iss. 6, pp. 1317-1328
Closed Access | Times Cited: 17
Peripheral protein inflammatory biomarkers in bipolar disorder and major depressive disorder: A systematic review and meta-analysis
Rajaram Gopalakrishnan, Yifan Wang, Flávio Kapczinski, et al.
Journal of Affective Disorders (2025)
Closed Access
Effects of kynurenine pathway metabolites on choroid plexus volume, hemodynamic response, and spontaneous neural activity: A new mechanism for disrupted neurovascular communication and impaired cognition in mood disorders
B. Bravi, Chiara Vitale, Palladini Mariagrazia, et al.
Brain Behavior and Immunity (2025) Vol. 125, pp. 414-427
Closed Access
Kynurenine pathway metabolites predict antianhedonic effects of electroconvulsive therapy in patients with treatment-resistant depression
Qing-Bin Zeng, Xingbing Huang, Rui‐Hua Xu, et al.
Journal of Affective Disorders (2025)
Closed Access
Causal Relationship between White Matter Tracts and Psychiatric Disorders: A Mendelian Randomization Study
Kai Yuan, Yifan Yu, Sizhi Ai, et al.
Research Square (Research Square) (2025)
Closed Access
Long-term effect of childhood trauma: Role of inflammation and white matter in mood disorders
Sara Poletti, Marco Paolini, Julia L. Ernst, et al.
Brain Behavior & Immunity - Health (2022) Vol. 26, pp. 100529-100529
Open Access | Times Cited: 16
New biomarkers in mood disorders: Insights from immunopsychiatry and neuroimaging
Francesco Benedetti, Benedetta Vai
European Neuropsychopharmacology (2023) Vol. 69, pp. 56-57
Open Access | Times Cited: 9
Correlations between multimodal neuroimaging and peripheral inflammation in different subtypes and mood states of bipolar disorder: a systematic review
Jingyi Long, Bo Li, Pei Dao Ding, et al.
International Journal of Bipolar Disorders (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Inflammatory biomarkers in depression: scoping review
Walter Paganin, Sabrina Signorini
BJPsych Open (2024) Vol. 10, Iss. 5
Open Access | Times Cited: 3
White matter microstructural and inflammation-based subgroups in bipolar disorder II depression differentiate in depressive and psychotic symptoms
Yuan Cao, Paulo Lizano, Meng Li, et al.
Journal of Affective Disorders (2024) Vol. 368, pp. 493-502
Closed Access | Times Cited: 2
T-cell immunophenotype correlations with cortical thickness and white matter microstructure in bipolar disorder
Andrea Escelsior, Alberto Inuggi, Bruno Sterlini, et al.
Journal of Affective Disorders (2023) Vol. 348, pp. 179-190
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top